Loading company…
MiCo BioMed develops and manufactures in-vitro diagnostic equipment, devices, and reagents.
Based in Seongnam, South Korea, MiCo BioMed develops and manufactures in-vitro diagnostic equipment and devices. Its products include lab chips, reagents, and equipment for molecular, biochemical, and immunodiagnostic testing. Founded in 2009, the company raised KRW 1.5 billion in venture funding in 2019. As of 2023, its CEO was Sung Kim.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in